Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

foralumab

A monoclonal antibody directed against cluster of differentiation 3 (CD3) epsilon, with immunomodulatory activity. Foralumab binds to CD3 epsilon on T cells, preventing T-cell activation and may also suppress immune responses. CD3 epsilon is a polypeptide that is part of the CD3-T cell receptor (TCR) complex.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

foralumab

Search NCI's Drug Dictionary